PTSD and other mental health treatment with opioid antagonist... - Galyn Forster, MS, LPC (2021 Conference) (LDN, low dose naltrexone)

 

New approaches to managing fibromyalgia pain - Ginevra Liptan, MD (2021 Conference) (LDN, low dose naltrexone)

 

Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD (2021 Conference) (LDN, low dose naltrexone)

 

Case Reports of Cancer Therapies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)

Dr. Khan believes in integrative care, combining allopathic and naturopathic therapies. They treat all types of cancer and people of all ages, with a focus on non-toxic therapy, and quality of life.

 

Tom O’Bryan, DC, CCN, DACBN - Dietary Triggers of Pain and Inflammation (2016 Conference) (LDN, low dose naltrexone)

Download Dr. O'Bryan's Dietary Triggers Presentation

 

Galyn Forster, MS, LPC - Treatment of Psychiatric Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Mr. Forster's Psych Disorders Presentation

 

Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Chopra's Pain Presentation

 

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

 

Pain - Samyadev Datta, MD (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

 

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning